A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these ...

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

【导读】胃肠道间质瘤（GIST）在临床上具有异质性，在个体患者中表现出不同程度的疾病侵袭性。团队全面描述了117例GIST队列的基因组和转录组学景观，包括来自105例患者的31例低风险、18例中危、29例高风险、34例转移性和5例新辅助GIST。20 ...

DelveInsight’s “Gastrointestinal Stromal Tumor Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Gastrointestinal Stromal Tumor, historical and ...

An eight-year-old girl from Meadow Lake, Sask., is proparing for an Ironkids race next month in Florida to raise money and ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List (NRDL) released by ...

Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Zai Lab Limited (ZLAB) announced the inclusion of AUGTYRO (repotrectinib) in China's National Reimbursement Drug List for ROS1+ ...